May 10 (Reuters) - A panel of independent experts to the
U.S. Food and Drug Administration on Wednesday unanimously voted
for the over-the-counter use of Perrigo Co's PRGO.N birth
control pill.
The FDA will likely follow the panel's non-binding
recommendation, that would make it possible for American women
to get access to the first birth control pill without a
prescription.
(Reporting by Sriparna Roy and Nandhini Srinivasan in
Bengaluru; Editing by Shailesh Kuber)
((Sriparna.Roy@thomsonreuters.com;))